金龙胶囊在宫颈癌术后调强放疗复发转移中的应用效果

Abstract
Figure/Table
References (17)
Related Citation (15)

Download: PDF (0 KB) HTML (38 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the application effect of Jinlong Capsules in the recurrence and metastasis examined by intensity modulated radiation therapy (IMRT) after cervical cancer surgery. Methods A total of 60 patients with postoperative cervical cancer who were admitted to Ganzhou Cancer Hospital from January 2017 to December 2019 were selected as the study subjects. The patients were divided into an observation group and a control group by the random number table method, with 30 cases in each group. The control group was treated with IMRT regimen, and the observation group was treated with Jinlong Capsule on the basis of IMRT. The recent clinical treatment effects, Karnofsky functional status (KPS) score, immune cell indicators, and adverse reactions were compared between the two groups.Results The short-term clinical treatment effect of the observation group was higher than that of the control group, and the difference was statistically significant (P＜0.05). Before treatment, there was no statistically significant difference in the KPS scores of the two groups of patients (P＜0.05); after treatment, the KPS scores of the two groups of patients were higher than before treatment, and the difference was statistically significant (P＜0.05); after treatment, The KPS score of the observation group was higher than that of the control group, and the difference was statistically significant (P＜0.05).Before treatment, there was no statistically significant difference in immune cell indicators between the two groups of patients (P＜0.05); after treatment, the immune cell indicators in the observation group were better than those before treatment, and the differences were statistically significant (P＜0.05); after treatment, The immune cell indexes of the observation group were better than those of the control group, and the differences were statistically significant (P＜0.05).The incidence of acute radiation enteritis, radiation cystitis and bone marrow suppression in the observation group were lower than those in the control group, and the differences were statistically significant (P＜0.05). Conclusion Jinlong Capsule combined with IMRT in the treatment of patients with cervical cancer after surgery has the effects of improving short-term clinical treatment effects, en hancing patient immune function, reducing adverse reactions and improving quality of life. It is worthy of further promotion and application.

Key words： Jinlong Capsules Intensity modulated radiation therapy Cervical cancer Efficacy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZENG Chun-sheng
	YU Ying
	XU Qing-yun
	WANG Xiao-mao
	LIAO Zhen-rong

Cite this article:

ZENG Chun-sheng,YU Ying,XU Qing-yun, et al. Application effects of Jinlong Capsules in the recurrence and metastasis examined by intensity modulated radiation therapy after cervical cancer surgery[J]. 中国当代医药, 2021, 28(28): 148-151.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I28/148

[1]	周琦，吴小华，刘继红，等.宫颈癌诊断与治疗指南（第四版）[J].中国实用妇科与产科杂志，2018，34（6）：613-622.
[2]	陈春林，黎志强.加强子宫颈癌患者诊治的全程管理[J].中国实用妇科与产科杂志，2021，37（1）：18-24.
[3]	周晖，刘昀昀，罗铭，等.《2021NCCN 子宫颈癌临床实践指南（第1 版）》解读[J].中国实用妇科与产科杂志，2020，36（11）：1098-1104.
[4]	邓波儿，孔为民.早期宫颈癌术后预后危险因素及治疗进展[J].医学综述，2018，24（22）：4475-4479.
[5]	李晓花，何纪恩.早期宫颈癌术后放疗预后的影响因素及生存质量分析[J].河北医药，2018，40（4）：584-586.
[6]	蒋军，张利文，廖珊，等.三维适形放疗、调强放疗和容积调强放疗在宫颈癌术后患者中的应用[J].广东医学，2020，41（23）：2426-2429.
[7]	罗丹，孔为民，陈姝宁.宫颈癌放疗后放射性直肠炎发生情况及其相关因素分析[J].医学综述，2021，27（2）：400-403，408.
[8]	甄宏楠，田园，沈晶，等.影响宫颈癌放疗患者生活质量因素的分析[J].基础医学与临床，2019，39（11）：1618-1622.
[9]	邝玉慧，陈欣菊，徐方飚.金龙胶囊联合放化疗治疗肝转移瘤的疗效与安全性Meta 分析[J].肿瘤防治研究，2020，47（1）：63-69.
[10]	李丹，金凤，陶丽，等.金龙胶囊对胃癌细胞MGC-803 和BGC-823 侵袭转移能力的影响[J].中国实验方剂学杂志，2018，24（19）：117-123.
[11]	李丹，刘延庆.金龙胶囊抗肿瘤的研究进展[J].湖北中医杂志，2018，40（8）：57-60.
[12]	Azam F，Latif MF，Farooq A，et al.Performance status assessment by using ECOG （Eastern Cooperative Oncology Group）score for cancer patients by oncology healthcare professionals[J].Case Rep Oncol，2019，12（3）：728-736.
[13]	Hiramoto S，Tamaki T，Nagashima K，et al.Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer[J].Int J Clin Oncol，2019，24（4）：454-459.
[14]	涂波，潘志华，肖科，等.宫颈癌放疗后的放射性直肠损伤患者MRI 影像学特征及诊断价值[J].实用癌症杂志，2020，35（4）：664-666，673.
[15]	Schwartz LH，Litière S，deVries E，et al.RECIST 1.1-update and clarification：from the RECIST committee[J].Eur J Cancer，2016，62：132-137.
[16]	雷冬梅.白头翁汤加减治疗急性放射性直肠炎（湿热火毒型）的临床疗效观察[D].成都中医药大学，2019.
[17]	赵雨薇.宫颈癌放疗患者T 淋巴细胞亚群计数的临床分析[D].大连：大连医科大学，2019.